Consistent with our previous reports [11], [12], our data show that fasting serum CXCL16 levels were significantly increased in subjects with CKD (2.65±0.11 ng/ml) compared with healthy subjects (1.30±0.05 ng/ml, p<0.05). The gene discussed is CXCL16; the disease is chronic kidney disease.